Literature DB >> 11053662

Fibroblast cultures from healthy centenarians have an active proteasome.

N Chondrogianni1, I Petropoulos, C Franceschi, B Friguet, E S Gonos.   

Abstract

Healthy centenarians represent the best example of successful ageing. Various studies have shown that centenarians have escaped the major age-associated diseases, they have several well-conserved immune parameters and at least one gene allele has been identified and linked with their increased longevity. During ageing there is an accumulation of oxidised proteins, a phenomenon that has been related to an impaired function of the 20S proteasome in aged cells. We have, therefore, analysed the expression and the proteolytic activity of the proteasome in centenarian cells. Four fibroblast cultures derived from healthy centenarians were studied and compared with cultures derived from adult donors of different ages. Analysis of several proteasome subunits RNA expression levels, determination of one peptidase activity and identification of oxidised proteins in these samples revealed that centenarian cultures have a functional proteasome. In addition, it was found that the centenarian cultures exhibit characteristics similar to the younger rather than the older control donors derived cultures in all three assays. These data indicate that centenarian cells may be different from elderly donors cells, thus opening up new dimensions for the identification and characterisation of factors that are linked with longevity.

Mesh:

Substances:

Year:  2000        PMID: 11053662     DOI: 10.1016/s0531-5565(00)00137-6

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  58 in total

1.  20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegans.

Authors:  Niki Chondrogianni; Konstantina Georgila; Nikos Kourtis; Nektarios Tavernarakis; Efstathios S Gonos
Journal:  FASEB J       Date:  2014-11-13       Impact factor: 5.191

2.  Mild heat stress stimulates 20S proteasome and its 11S activator in human fibroblasts undergoing aging in vitro.

Authors:  Rasmus Beedholm; Brian F C Clark; Suresh I S Rattan
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

Review 3.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

Review 4.  Aging and regulated protein degradation: who has the UPPer hand?

Authors:  Vita A Vernace; Thomas Schmidt-Glenewinkel; Maria E Figueiredo-Pereira
Journal:  Aging Cell       Date:  2007-08-06       Impact factor: 9.304

Review 5.  A synopsis on aging-Theories, mechanisms and future prospects.

Authors:  João Pinto da Costa; Rui Vitorino; Gustavo M Silva; Christine Vogel; Armando C Duarte; Teresa Rocha-Santos
Journal:  Ageing Res Rev       Date:  2016-06-25       Impact factor: 10.895

Review 6.  Cellular Metabolism and Aging.

Authors:  Andre Catic
Journal:  Prog Mol Biol Transl Sci       Date:  2018-02-01       Impact factor: 3.622

7.  Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts.

Authors:  Suzanne Kapeta; Niki Chondrogianni; Efstathios S Gonos
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

Review 8.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

9.  Lifespan of mice and primates correlates with immunoproteasome expression.

Authors:  Andrew M Pickering; Marcus Lehr; Richard A Miller
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

10.  Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress.

Authors:  Eleni N Tsakiri; Gerasimos P Sykiotis; Issidora S Papassideri; Vassilis G Gorgoulis; Dirk Bohmann; Ioannis P Trougakos
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.